Adaptimmune Therapeutics plc (MUN:473A)
Germany · Delayed Price · Currency is EUR 0.0158
+0.0090 (132.35%)
Last updated: May 14, 2026, 4:32 PM CET
Adaptimmune Therapeutics Market Cap
Adaptimmune Therapeutics has a market cap or net worth of €4.53 million as of May 14, 2026. Its market cap has decreased by -92.57% in one year.
Market Cap
4.53M
Enterprise Value
23.84M
Revenue
55.42M
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.02
Market Cap Chart
Since May 7, 2015, Adaptimmune Therapeutics's market cap has decreased from 1.08B to 4.53M, a decrease of -99.58%. That is a compound annual growth rate of -39.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 4.53M | -22.87% |
| Dec 31, 2025 | 5.87M | -95.59% |
| Dec 31, 2024 | 133.14M | -18.29% |
| Dec 29, 2023 | 162.94M | -27.20% |
| Dec 30, 2022 | 223.81M | -56.55% |
| Dec 31, 2021 | 515.06M | -24.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biotest Aktiengesellschaft | 1.43B |
| Darwin AG | 92.40M |
| 2invest AG | 45.29M |
| Biomark Diagnostics | 35.73M |
| Paion AG | 456.56K |
| co.don AG | 360.77K |
| bioXXmed AG | 222.93K |
| MagForce AG | 107.00K |